Global University Venturing

State lawmakers are considering plans to fund supports for Maryland’s cybersecurity and life sciences sectors administered by local economic development agency Tedco.

Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.

Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.

Christine Gulbranson, chief innovation officer of University of California, continues her deep-dive into the institution's ecosystem and offers six case studies illustrating how spinouts and startups have grown.

Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.

UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.

Complion collected funding from investors including the multi-university-backed Ohio Innovation Fund for its regulatory compliance software platform catered to sites conducting clinical research.

Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.

Richard Chylla, executive director of MSU Technologies, has taken over as chairman of Autm's board of directors, succeeding Alison Campbell.

University of Minnesota's Discovery Launchpad incubator is currently supporting eight projects based on university research with resources including office space and mentoring.

Cédric Van Nevel has departed Bekaert to become an investment manager at Qbic, a venture fund manager focused on spinouts of Ghent, Brussels and Antwerp universities and of Vito.